Showing results (371-380 of 650) with videos related to

Sort By:
Pageof 65
Journal of the American Chemical Society|August 25, 2022
Characterization of Binding Site Interactions and Selectivity Principles in the α3β4 Nicotinic Acetylcholine ReceptorHailey J Knox, Hugo Rego Campello, Henry A Lester, et al.
Molecular Pharmacology|May 1, 1989
Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding siteR A Lester, M L Quarum, J D Parker, et al.
Journal of the American Medical Informatics Association : JAMIA|August 5, 2022
Implementation outcomes of the Structured and Codified SIG format in electronic prescription directionsCorey A Lester, Allen J Flynn, Vincent D Marshall, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|March 15, 2026
Pharmacokinetics and Analgesic Efficacy of a Novel Extended-Release Buprenorphine Formulation in MiceStephanie Yang, Christopher D Fry, Laura B Durham, et al.
Biophysical Journal|January 13, 2009
Single-molecule imaging of a fluorescent unnatural amino acid incorporated into nicotinic receptorsRigo Pantoja, Erik A Rodriguez, Mohammed I Dibas, et al.
Iranian Journal of Public Health|November 30, 2012
Prevalence of hepatitis C virus genotypes in mashhad, northeast iranH Vossughinia, LA Goshayeshi, H Rafatpanah Bayegi, et al.
American Journal of Physiology. Cell Physiology|June 13, 2001
Incorporation of caged cysteine and caged tyrosine into a transmembrane segment of the nicotinic ACh receptorK D Philipson, J P Gallivan, G S Brandt, et al.
The Journal of General Physiology|August 1, 1991
Low molecular weight mRNA encodes a protein that controls serotonin 5-HT1c and acetylcholine M1 receptor sensitivity in Xenopus oocytesA E Walter, J H Hoger, C Labarca, et al.
Communicable Diseases Intelligence Quarterly Report|August 4, 2010
Evaluation of Campylobacter infection surveillance in VictoriaNathan J Grills, Stacey L Rowe, Joy E Gregory, et al.
British Journal of Haematology|October 3, 2002
Successful treatment of congenital thrombotic thrombocytopenic purpura using the intermediate purity factor VIII concentrate BPL 8YWill A Lester, Michael D Williams, Sarah L Allford, et al.
Pageof 65